Additionally, it serves as a downregulator of the insulin and leptin signalling pathway, catalysing the dephosphorylation of insulin receptor (IR) and insulin receptor substrate (IRS) which contributes to the pathogenesis of T2DM and obesity by the induction of insulin and leptin resistance, respectively [8]. The gene discussed is INS; the disease is obesity disorder.